Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Clover Biopharmaceuticals Ltd. ( (HK:2197) ) is now available.
Clover Biopharmaceuticals Ltd. announced changes to its board of directors and committee memberships, effective July 1, 2025. Dr. Donna Marie Ambrosino and Mr. Xiang Liao have been appointed as members of the Nomination Committee, reflecting the company’s ongoing efforts to strengthen its governance structure.
More about Clover Biopharmaceuticals Ltd.
Clover Biopharmaceuticals Ltd. is a company incorporated in the Cayman Islands, focusing on the biopharmaceutical industry. It is involved in the development and commercialization of innovative vaccines and biologic therapeutic products.
Average Trading Volume: 1,252,715
Technical Sentiment Signal: Hold
Current Market Cap: HK$376.1M
Find detailed analytics on 2197 stock on TipRanks’ Stock Analysis page.